Home / Conditions (page 57)

Conditions

CONDITIONS

The Dangers of Undiagnosed Eating Disorders in Patients with Type 1 Diabetes

Patients with type 1 diabetes and eating disorders have a greater risk of diabetic ketoacidosis and all-cause mortality.  Eating disorders are severe illnesses associated with abnormal eating patterns secondary to pre-occupations with body weight and body image. Some examples of eating disorders include anorexia nervosa, bulimia nervosa, and binge eating …

Read More »

The Role of Pharmacists in Diabetes Education

Pharmacists in the community setting play a role in diabetes screening and management by providing direct patient care. With the constant increase in the prevalence of diabetes, education is vital in understanding how to control disease progression. Pharmacists play an essential role in disease management, assessing medication adherence, and educating …

Read More »

Diabetic Foot Disease and Oedema

Patients with diabetes are likely to be affected by Diabetic foot ulcers (DFUs). This type of disease is popular and enfeeble, generating a surge of serious morbidity and mortality combined with worldwide socio-economic problems. The symptoms of this disease such as infection and inflammation raise surrounding oedema of the foot. …

Read More »

Sickle Cell Disease and Diabetes Mellitus

Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …

Read More »

Influence of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus

Sodium-glucose cotransporter 2 inhibitors lower the risk of hospitalization in heart failure and cardiovascular death…  The SIMPLE trial examined the effects of empagliflozin on myocardial flow reserve, showing microvascular perfusion in individuals with type 2 diabetes with high CVD risk. The SIMPLE trial is a single-center, double-blind, randomized clinical trial …

Read More »

The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease

Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …

Read More »